Neuroone Medical Technologies (NMTC) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to 0.75.
- Neuroone Medical Technologies' Equity Ratio rose 6513.37% to 0.75 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.75, marking a year-over-year increase of 6513.37%. This contributed to the annual value of 0.66 for FY2025, which is 32836.98% up from last year.
- Latest data reveals that Neuroone Medical Technologies reported Equity Ratio of 0.75 as of Q4 2025, which was up 6513.37% from 0.66 recorded in Q3 2025.
- Neuroone Medical Technologies' 5-year Equity Ratio high stood at 0.93 for Q1 2022, and its period low was 0.15 during Q3 2024.
- In the last 5 years, Neuroone Medical Technologies' Equity Ratio had a median value of 0.76 in 2023 and averaged 0.72.
- Per our database at Business Quant, Neuroone Medical Technologies' Equity Ratio skyrocketed by 42153.39% in 2021 and then plummeted by 8016.59% in 2024.
- Neuroone Medical Technologies' Equity Ratio (Quarter) stood at 0.93 in 2021, then fell by 8.85% to 0.85 in 2022, then decreased by 10.3% to 0.76 in 2023, then crashed by 40.44% to 0.45 in 2024, then skyrocketed by 65.13% to 0.75 in 2025.
- Its last three reported values are 0.75 in Q4 2025, 0.66 for Q3 2025, and 0.76 during Q2 2025.